Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 603 for hematology

Edit search filters
  1. Study Of Biomarker-Based Treatment Of Acute Myeloid Leukemia

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Reduced Craniospinal Radiation Therapy And Chemotherapy In Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

    Rochester, MN

  3. A Study To Evaluate Gilteritinib Vs. Midostaurin In FLT3 Mutated Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

  4. Brentuximab Vedotin And Nivolumab With Or Without Ipilimumab In Treating Patients With Relapsed Or Refractory Hodgkin Lymphoma

    Rochester, MN

  5. Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

    Scottsdale/Phoenix, AZ

  6. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, And Nivolumab In Treating Patients With Stage I-II Hodgkin Lymphoma

    Rochester, MN

  7. A Study To Compare Tisagenlecleucel Vs. Standard Of Care In Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

    Jacksonville, FL

  8. A Dose Escalation And Confirmation Study Of PT-112 In Advanced Solid Tumors In Combination With Avelumab

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Randomized, Open-label Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy after Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

    Rochester, MN

  10. Z-Endoxifen Hydrochloride in Treating Patients with Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer